Blog
RSS FeedPosted by Michael Wonder on 16 Nov 2017
NZAF welcomes PHARMAC’s milestone proposal to fund pre-exposure prophylaxis
16 November 2017 - In a proposal released this week, PHARMAC has announced its intention to fund the HIV-prevention drug ...
Posted by Michael Wonder on 15 Nov 2017
Proposal to widen funded access to pulmonary arterial hypertension treatments
15 November 2017 - PHARMAC is seeking feedback on a proposal to make several changes to the funding of medicines ...
Posted by Michael Wonder on 14 Nov 2017
Proposal to widen access to various anti-infectives
14 November 2017 - PHARMAC is seeking feedback on three proposals to widen funded access, from 1 January 2018, to ...
Posted by Michael Wonder on 14 Nov 2017
Proposal to fund HIV pre-exposure prophylaxis (PrEP)
14 November 2017 - PHARMAC is seeking feedback on a proposal to widen funded access to emtricitabine with tenofovir disoproxil fumarate ...
Posted by Michael Wonder on 08 Nov 2017
Proposal to list methylnaltrexone bromide
8 November 2017 - PHARMAC is seeking feedback on a proposal to list methylnaltrexone bromide (Relistor) 12 mg/0.6 mL injection in ...
Posted by Michael Wonder on 31 Oct 2017
Proposal to widen access to zoledronic acid for early breast cancer
31 October 2017 - PHARMAC proposes to widen funded access to zoledronic to include adjuvant use in post-menopausal women with ...
Posted by Michael Wonder on 04 Oct 2017
Proposal to list a range of medical thermometer products and medical devices used in the prevention of venous thromboembolisms supplied by Medtronic
4 October 2017 - PHARMAC is seeking feedback on a proposal to list a range of medical thermometer and venous thromboembolism ...
Posted by Michael Wonder on 16 Sep 2017
Proposal to fund dexamethasone ocular implants for DMO
15 September 2017 - PHARMAC is seeking feedback on a proposal to list dexamethasone 700 mcg ocular implants (Ozurdex) through ...
Posted by Michael Wonder on 16 Sep 2017
Proposal to fund zoster vaccine
15 September 2017 - PHARMAC is seeking feedback on a proposal to fund the zoster vaccine (Zostavax) for the prevention ...
Posted by Michael Wonder on 11 Sep 2017
Iron infusions in the community
11 September 2017 - Eligible people will now be able to receive ferric carboxymaltose iron infusions in some general practitioners’ ...
Posted by Michael Wonder on 24 Jul 2017
Nicotine replacement therapy
21 July 2017 - PHARMAC proposes to continue to fund the Habitrol brand of nicotine gum, lozenges and patches supplied ...
Posted by Michael Wonder on 20 Jul 2017
Proposal to change aripiprazole access and brand
20 July 2017 - PHARMAC proposes two key changes to the funding of aripiprazole tablets, an antipsychotic medicine for use ...
Posted by Michael Wonder on 20 Jul 2017
Change of access to funded nicotine replacement therapy and the emergency contraceptive pill
20 July 2017 - PHARMAC is seeking feedback on a proposal that would give pharmacists the ability to provide some ...
Posted by Michael Wonder on 21 Jun 2017
Agreement with ArjoHuntleigh Limited for the supply of medical devices used in the prevention of venous thromboembolism
21 June 2017 - PHARMAC is pleased to announce the approval of an agreement with ArjoHuntleigh for the supply of ...
Posted by Michael Wonder on 13 Jun 2017
Proposal to list a range of Interventional Cardiology products supplied by Edwards Lifesciences
13 June 2017 - PHARMAC is seeking feedback on a proposal to list a range of Interventional Cardiology products supplied ...